Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
medmix AG is a precision delivery device company operating primarily in the healthcare and industrial sectors. Its core business involves developing and manufacturing high-precision delivery devices used in a variety of applications, including healthcare, consumer, and industrial segments. The company offers a range of products such as drug delivery devices, dental applicators, and industrial mixing solutions. Headquartered in Switzerland, medmix has a global presence with a network that supports its diverse client base. The company focuses on leveraging its expertise in high-precision engineering to offer innovative solutions that meet specific industry needs.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
medmix AGEli Lilly
Last price
CHF 9.80$1,157.13
Currency
CHF
USD
CHF 403M$1T
-38.36
-CHF 0.00$29.79
0.820.50
CHF 0.10$6.69
1.01%0.61%
Sector
HealthHealth
Employees
2,58750,000
Ticker
Fr. MEDX$LLY
Primary listing
XSWXNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in Fr.MEDX or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.